Adam Spice
Analyst · Cantor Fitzgerald
Thanks, Pete. Third quarter 2026 revenue was a record $267.8 million, coming in above our prior guidance range of $250 million to $265 million and representing year-over-year growth of 73%. Revenue increased by 14.4% sequentially driven by strong contribution from both business segments, highlighting continued momentum across the business. Our Space Systems segment delivered $214.8 million in revenue for the quarter, reflecting a sequential increase of 13.3%. This growth was primarily driven by continued scaling of our satellite platform business along with full quarter contributions from our laser communications and our robotics acquisitions. We also delivered sequential organic growth across our other component and software businesses. Our Space Systems business continues to perform exceptionally well and provides diversification alongside our robust but at times lumpy launch business. Meanwhile, our Launch Services segment generated $53.1 million in revenue, representing a 19% quarter-over-quarter increase, driven by a 2 launch increase in point-in-time Electron missions where the full value of the launch is reflected at launch. Now turning to gross margin. GAAP gross margin for the third quarter was 33.6%, above our prior guidance range of 29% to 31%. Non-GAAP gross margin for the third quarter was 38.4%, which was above our prior guidance range of 35% to 37%. Consistent with our Q3 guidance, margins declined sequentially, primarily driven by the first full quarter contribution from our recent acquisition, Mynaric, which brings laser communications capabilities to our portfolio as well as the lack of tariff refunds that benefited Q2 margins. The decline was smaller than we anticipated, however, due to upside in our component businesses profitability led by solar and our Geost acquisitions optical systems, as well as launch favorability driven by reduced production spend and favorable absorption due to a step-up in Electron launch and build cadence. As previously mentioned, Mynaric will take a few quarters to reach target margins as we align the cost structure, scale production and implement the Rocket Lab operating system. Additionally, we recorded a forward loss reserve against our Neutron Flight 2 launch vehicle to reflect a nascent stage of the vehicle and related early launch capability and potential impact to that specific flight's profitability or lack thereof. Relatedly, we ended Q3 with production-related headcount of 1,728, up 40% from the prior quarter. Turning to backlog. We ended Q3 2026 with approximately $3.6 billion in total backlog, up 52% sequentially from approximately $2.4 billion at the end of Q2 with launch backlog accounting for approximately 52% and Space Systems representing 48%. We signed a significant volume of contracts across launch and Space Systems in the third quarter, bringing our backlog to 117 launches and over 55 spacecraft and making 2026 an incredible year of backlog growth thus far. As Pete mentioned, we signed 54 launches in the quarter, 8 of which were for Neutron with multiple contracts at a new escalated base price of $70 million. Underscoring the growing demand and scarcity for medium-lift launch capacity. While bookings across launch and Space Systems remain inherently lumpy due to the timing of larger high-impact program opportunities, backlog has grown even as we recognize revenue at a meaningfully higher run rate. We continue to pursue additional needle-moving contract opportunities that we expect will enable us to sustain healthy backlog levels as revenue continues to scale. Looking ahead, we expect approximately 32.9% of our current backlog to convert into revenue within the next 12 months. Additionally, we continue to benefit from relatively quick-turn business across launch and Space Systems components businesses that drive incremental top line contribution beyond the current 12-month backlog conversion. Turning to operating expenses. GAAP operating expenses for the third quarter were $169.3 million, above our guidance range of $143 million to $149 million. Non-GAAP operating expenses for the third quarter were $130.2 million, which was modestly above our guidance range of $121 million to $127 million. The increase in GAAP operating expenses relative to our prior guidance was primarily driven by transaction costs associated with the pending acquisition of Iridium, including a $9.4 million expense associated with the change of control of Iridium's existing Term Loan B facility, which was completed during the quarter. But neither the success nor cost could be estimated or predicted at the time we provided our Q3 guidance. In R&D specifically, GAAP expenses increased $16 million quarter-over-quarter, while non-GAAP expenses rose $17.2 million. These increases were primarily driven by Neutron Flight 1 development and production activity, particularly engine production and carbon composite structures as we progress towards launch. Q3 ending R&D headcount was 1,084 representing a decrease of 3% from the prior quarter. In SG&A, GAAP expenses increased $11.2 million quarter-over-quarter, while non-GAAP expenses decreased $2.8 million. The increase in GAAP SG&A was primarily due to transaction fees associated with the pending Iridium acquisition that I referenced earlier. The decline in non-GAAP SG&A was primarily driven by early progress in realizing cost synergies from our Mynaric acquisition. Q3 ending SG&A headcount was 447 representing an increase of 5% from the prior quarter. In summary, total headcount at the end of the third quarter was 3,259, up 42 heads from the prior quarter. Turning to cash. Purchases of property, equipment and capitalized software licenses were $31.1 million in the third quarter of 2026, an increase of $5 million from the $26 million in the second quarter. This increase reflects continued investment in Neutron, including the Return On Investment recovery barge and launch and testing infrastructure. As we progress towards Neutron's first flight and into production, we expect capital expenditures to remain elevated as we invest in testing, production scaling and infrastructure expansion. GAAP EPS for the third quarter was a loss of $0.12 per share compared to a loss of $0.08 per share in the second quarter. The sequential increase in GAAP loss per share was primarily driven by transaction costs in SG&A and other income, mostly due to the termination of the bridge loan commitment related to the pending Iridium acquisition referenced earlier. Spend also rose on Neutron engine prototyping and composites for the Flight 1 engine set and Stage 1 tank rebuild. We expect Neutron spend to remain elevated through first launch driven by engine materials and the team's labor run rate as costs shift towards subassembly test campaigns and vehicle integration. GAAP operating cash flow was a positive $7.2 million in the third quarter of 2026 compared to a use of $84.1 million in the second quarter. This increase is primarily due to a step-up in milestone payments on satellite programs, which are lumpy and increasing in magnitude. Similar to the capital expenditure dynamics mentioned earlier, cash consumption will remain elevated due to Neutron development and Neutron qual production as we scale the business and as we procure longer lead items for our SDA programs. Overall, non-GAAP free cash flow, defined as GAAP operating cash flow less purchases of property, equipment and capitalized software in the third quarter of 2026 was a use of $23.9 million, compared to a use of $110.1 million in the second quarter. The ending balance of cash, cash equivalents, restricted cash and marketable securities was roughly $4.7 billion at the end of the third quarter. The sequential increase in liquidity was driven by proceeds from sales of our common stock under our at-the-market equity offering programs, which generated approximately $2.4 billion in gross proceeds through the issuance of 36.8 million shares, and we completed this program in September. Together with Iridium's amended term loan facility and our available liquidity, these proceeds fully fund the cash consideration and other funds necessary for our pending acquisition of Iridium, which allowed us to terminate our $3.6 billion bridge facility commitment. We exited Q3 in a strong position to execute on both organic and inorganic growth initiatives, including further vertically integrating our supply chain, expanding our strategic capabilities and growing our addressable market, consistent with what we've done successfully in the past. Adjusted EBITDA loss for the third quarter of 2026 was $18 million, which was towards the low end of our guidance range of $17 million to $23 million loss. The sequential $9.2 million increase in adjusted EBITDA loss was primarily driven by elevated R&D spending due to Neutron. With that, let's turn to our guidance for the fourth quarter of 2026. We expect revenue in the fourth quarter to range between $270 million and $290 million, representing 4.5% quarter-over-quarter revenue growth at the midpoint and growth of 55.9% from the year ago quarter. We expect strong growth in launch revenue with a pickup in both point in time and overtime revenues, partially offset by a decline in Space Systems. Within Space Systems, solar and satellite platforms are expected to decline coming off a very strong Q3 performance, while the rest of Space Systems businesses should be up. We expect GAAP gross margin to range between 34% to 36% and non-GAAP gross margin to range between 39% to 41%. Margins are expected to improve sequentially due to improved mix between launch and Space Systems and within Space Systems. We expect fourth quarter GAAP operating expenses to range between $162 million and $168 million and non-GAAP operating expenses to range between $136 million and $142 million. The quarter-on-quarter increases are primarily driven by Neutron development, testing and readiness activities ahead of Flight 1. We continue to expect a shift in spending from R&D to Flight 2 and subsequent Neutron production inventory which is an encouraging sign of progress as we move closer to Neutron's first flight and supports our path towards meaningful operating leverage and positive cash flow in the future. We expect fourth quarter net interest income to be $45 million, which is generally a function of our elevated cash balance. We expect fourth quarter adjusted EBITDA loss to range between $14 million and $20 million and basic weighted average common shares outstanding to be approximately 681 million shares. Lastly, consistent with prior quarters, we expect negative non-GAAP free cash flow in the fourth quarter to remain at elevated levels driven by ongoing investments in Neutron development and scaling production. In summary, Q3 was another quarter of strong execution. We exceeded guidance for revenue and gross margins, grew backlog to a record $3.6 billion and continue to maintain robust liquidity to fund future growth initiatives. We expect this momentum to continue, guiding to increased revenue growth as our satellite platforms business scales and Neutron progresses towards its first flight. We continue to execute across all metrics and are positioned to create significant value ahead. Last but not least, here are some of the upcoming investor events that we'll be attending in the next few months. And with that, we'll hand the call over to the operator for questions.